Granza Bio

Granza Bio is a biotechnology service provider that develops a novel delivery "shell" platform, focusing on delivering immunotherapies and other "attack particles" to different parts of the body. The company's platform aims to target cancer cells, prevent unnecessary toxicity and adverse side effects, enabling cancer patients to receive effective treatments they need.